Characteristics | Number | Percentile (%) | |
---|---|---|---|
Gender | Male | 37 | 71.2 |
Female | 15 | 28.8 | |
Age | Median | 44 | |
Range | 26-68 | ||
T stage | T1 | 6 | 11.5 |
T2 | 23 | 44.2 | |
T3 | 14 | 26.9 | |
T4 | 9 | 17.3 | |
Clinical stage | II | 29 | 55.8 |
III | 14 | 26.9 | |
IV | 9 | 17.3 | |
Neoadjuvant chemotherapy | Yes | 44 | 84.6 |
No | 8 | 15.4 | |
Concurrent chemotherapy | Yes | 45 | 86.5 |
No | 7 | 13.5 | |
Neck boost | No | 43 | 58.2 |
EB boost | 9 | 17.3 |